glycyrrhetinic acid and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

glycyrrhetinic acid has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, JP; Bruyère, C; Bury, M; Chaix, F; Delporte, C; Dubois, J; Gelbcke, M; Ghostin, J; Jabin, I; Kiss, R; Lallemand, B; Mathieu, V; Prévost, M	1

Other Studies

1 other study(ies) available for glycyrrhetinic acid and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

Article	Year
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity. Journal of medicinal chemistry, 2011, Oct-13, Volume: 54, Issue:19 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; Humans; Mice; Models, Molecular; Phenylurea Compounds; PPAR gamma; Proteasome Inhibitors; Protein Kinase Inhibitors; Structure-Activity Relationship	2011

Article

Year

N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.

Journal of medicinal chemistry, 2011, Oct-13, Volume: 54, Issue:19

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; Humans; Mice; Models, Molecular; Phenylurea Compounds; PPAR gamma; Proteasome Inhibitors; Protein Kinase Inhibitors; Structure-Activity Relationship

2011